Literature DB >> 24706261

Intraoperative staging by surgeons in patients with rectal cancer after preoperative chemoradiation: diagnostic accuracy and prognostic value.

Jung Wook Huh1, Woo Yong Lee, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun.   

Abstract

PURPOSE: Prognostic significance of intraoperative staging by surgeons and its possible complementary role with the pathological stage for evaluating the prognosis of rectal cancer after preoperative chemoradiation (CRT) is unknown. The goal of this study is to evaluate the diagnostic accuracy and prognostic role of intraoperative surgical staging by surgeons in patients with rectal cancer after preoperative CRT.
METHODS: A total of 267 consecutive patients with rectal cancer who underwent preoperative CRT and radical resection from December 2007 to March 2010 were retrospectively reviewed. Surgical staging was evaluated by determining its diagnostic accuracy and analyzing its prognostic significance.
RESULTS: Sensitivity, specificity, positive predictive value, and negative predictive value of intraoperative diagnosis of good responders (ypT0-2) were 78, 67, 53, and 86 %, respectively. The overall accuracy of good responders by surgeons was 71 %. A multivariate analysis revealed that pretreatment N stage and maximal tumor diameter were independent predictors for accordance of surgical and pathological diagnoses in T staging. The 3-year disease-free survival rates of the patients with surgical T0, T1, T2, T3, and T4 were 100, 94, 85, 84, and 58 %, respectively, and 86, 81, and 67 % for patients with surgical N0, N1, and N2 disease, respectively (P < 0.001 and P = 0.022, respectively). On multivariate analysis, surgical T stage was an independent prognostic factor for both disease-free survival and local recurrence.
CONCLUSION: Intraoperative surgical tumor staging by surgeons may be an important predictor of survival in patients with rectal cancer after preoperative CRT.

Entities:  

Mesh:

Year:  2014        PMID: 24706261     DOI: 10.1007/s00432-014-1657-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation.

Authors:  Jung Wook Huh; Yoon Ah Park; Eun Joo Jung; Kang Young Lee; Seung-Kook Sohn
Journal:  J Am Coll Surg       Date:  2008-04-14       Impact factor: 6.113

2.  Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.

Authors:  Chan Ho Park; Hee Cheol Kim; Yong Beom Cho; Seong Hyeon Yun; Woo Yong Lee; Young Suk Park; Doo Ho Choi; Ho-Kyung Chun
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

Authors:  Julio García-Aguilar; Enrique Hernandez de Anda; Prayuth Sirivongs; Suk-Hwan Lee; Robert D Madoff; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

4.  Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.

Authors:  J M C Yeung; V Kalff; R J Hicks; E Drummond; E Link; Y Taouk; M Michael; S Ngan; A C Lynch; A G Heriot
Journal:  Dis Colon Rectum       Date:  2011-05       Impact factor: 4.585

5.  Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Arvydas Vanagunas; David E Lin; Steven J Stryker
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

Review 6.  The role of comprehensive surgical staging in patients with endometrial cancer.

Authors:  Peter J Frederick; J Michael Straughn
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

7.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

Review 9.  Biomarkers for response to neoadjuvant chemoradiation for rectal cancer.

Authors:  Jeffrey G Kuremsky; Joel E Tepper; Howard L McLeod
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-01       Impact factor: 7.038

10.  Preoperative chemoradiation followed by transanal excision for rectal cancer.

Authors:  Jung Wook Huh; Eun Joo Jung; Yoon Ah Park; Kang Young Lee; Seung-Kook Sohn
Journal:  J Surg Res       Date:  2007-09-14       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.